4//SEC Filing
Van der Ploeg Leonardus H.T. 4
Accession 0001104659-19-032725
CIK 0001649904other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:01 PM ET
Size
18.2 KB
Accession
0001104659-19-032725
Insider Transaction Report
Form 4
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2019-05-28$25.38/sh−10,000$253,800→ 42,339 total - Exercise/Conversion
Common Stock
2019-05-29$4.59/sh+5,000$22,950→ 47,339 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-05-28+9,860→ 23,611 totalExercise: $4.59Exp: 2025-11-16→ Common Stock (9,860 underlying) - Exercise/Conversion
Common Stock
2019-05-28$6.14/sh+140$860→ 52,339 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-05-29+5,000→ 18,611 totalExercise: $4.59Exp: 2025-11-16→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2019-05-28$4.59/sh+9,860$45,257→ 52,199 total - Sale
Common Stock
2019-05-29$25.51/sh−5,000$127,550→ 42,339 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-05-28+140→ 55,290 totalExercise: $6.14Exp: 2027-04-04→ Common Stock (140 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $25.01 to $26.10, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $25.18 to $26.02, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
- [F4]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001615726
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:01 PM ET
- Size
- 18.2 KB